Status:
COMPLETED
MISA to NRDS：a Multicenter Study in China
Lead Sponsor:
Peking University Third Hospital
Conditions:
Bronchopulmonary Dysplasia
Patent Ductus Arteriosus
Eligibility:
All Genders
1-4 years
Phase:
NA
Brief Summary
BACKGROUND Treatment of neonatal respiratory distress syndrome with exogenous surfactant and mechanical ventilation made millions of preterm infants survived in neonatal intensive care unit (NICU). En...
Eligibility Criteria
Inclusion
- preterm infants born before 32 weeks gestational age
- spontaneously breathing receiving continuous positive airway pressure (CPAP) or NIPPV (Non-invasive positive pressure ventilation) without intubation
- clinical diagnosis of respiratory distress syndrome.
Exclusion
- with obvious malformations
- with asphyxia requiring intubation during resuscitation
- need endotracheal intubation or mechanical ventilation before surfactant administration.
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2019
Estimated Enrollment :
237 Patients enrolled
Trial Details
Trial ID
NCT04077333
Start Date
July 1 2017
End Date
March 30 2019
Last Update
September 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, China